Table 2

Characteristics of macrolide resistance in Mycoplasma genitalium specimens by gender (Alberta STI clinics, January to April 2016, n=92)

CategoryMacrolide resistanceGrand total
FemaleMale
Resistance (n=22)Susceptible (n=23)Total (n=45)p ValueResistance (n=30)Susceptible (n=17)Total (n=47)p Value
Median age (IQR)22 (20–26)26 (22–29)24 (20–28)0.0429 (23–41)27 (25–40)28 (24–41)0.9026 (22–31)
Ethnicity
Caucasian10 (45.5)12 (54.5)22 (50.0)0.8322 (75.9)14 (87.5)36 (80.0)0.8058 (65.2)
Indigenous6 (27.3)5 (22.7)11 (25.0)1 (3.4)01 (2.2)12 (13.5)
Other6 (27.3)5 (22.7)11 (25.0)6 (20.7)2 (12.5)8 (17.8)19 (21.3)
Sexual partners
Heterosexual14 (48.3)13 (81.3)27 (60.0)0.06
Same sex15 (51.7)3 (18.8)18 (40.0)
Testing location
Calgary5 (22.7)8 (34.8)13 (28.9)0.3710 (33.3)9 (52.9)19 (40.4)0.1932 (34.8)
Edmonton17 (77.3)15 (65.2)32 (71.1)20 (66.7)8 (47.1)28 (59.6)60 (65.2)
Symptomatic
No15 (68.2)14 (63.6)29 (65.9)0.7515 (51.7)11 (68.8)26 (57.8)0.2755 (61.8)
Yes7 (31.8)8 (36.4)15 (34.1)14 (48.3)5 (31.3)19 (42.2)34 (38.2)
HIV status
Negative19 (95.0)16 (80.0)35 (87.5)0.3420 (71.4)8 (50.0)28 (63.6)0.1163 (75.0)
Positive0002 (7.1)02 (4.5)2 (2.4)
Unknown1 (5.0)4 (20.0)5 (12.5)6 (21.4)8 (50.0)14 (31.8)19 (22.6)
Coinfections
Chlamydia3 (13.6)7 (30.4)10 (22.2)0.283 (10.0)2 (11.8)5 (10.6)1.0015 (16.3)
Gonorrhoea2 (9.1)2 (8.7)4 (8.9)1.002 (6.7)02 (4.3)0.536 (6.5)
MPC/NGU0006 (20.0)3 (17.6)9 (19.1)1.00
  • Missing data: ethnicity (female=1, male=2), symptomatic (female=1, male=2), HIV status (female=5, male=3), sexual partners=2.

  • MPC, mucopurulent cervicitis; NGU, non-gonococcal urethritis.